Versant Venture Management as of Sept. 30, 2020
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 11 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| CRISPR Therapeutics Common Stock (CRSP) | 55.6 | $304M | 3.6M | 83.64 | |
| Adverum Biotechnologies Common Stock | 13.2 | $72M | 7.0M | 10.30 | |
| Aprea Therapeutics Common Stock | 8.2 | $45M | 1.9M | 24.06 | |
| Flexion Therapeutics Common Stock | 7.3 | $40M | 3.8M | 10.41 | |
| Crinetics Pharmaceuticals Common Stock (CRNX) | 5.8 | $32M | 2.0M | 15.67 | |
| Akero Therapeutics Common Stock (AKRO) | 4.4 | $24M | 778k | 30.79 | |
| Ocular Therapeutix Common Stock (OCUL) | 3.1 | $17M | 2.2M | 7.61 | |
| Gritstone Oncology Common Stock (GRTS) | 1.5 | $8.2M | 3.1M | 2.65 | |
| CymaBay Therapeutics Common Stock | 0.7 | $3.9M | 544k | 7.24 | |
| Clovis Oncology Common Stock | 0.1 | $594k | 102k | 5.83 | |
| Second Sight Medical Products Common Stock | 0.1 | $484k | 562k | 0.86 |
